GlaxoSmithKline Pharmaceuticals Ltd. | Balance Sheet
Fiscal year is April-March. All values INR Millions.
2013
2015
2016
2017
2018
2019
Cash & Short Term Investments
20,516
19,106
13,919
8,996
12,964
11,713
Total Accounts Receivable
1,948
2,370
1,817
2,721
2,051
2,105
Inventories
3,470
3,756
5,259
4,258
5,289
5,143
Other Current Assets
306
3,158
743
768
1,560
1,134
Total Current Assets
26,239
28,389
21,737
16,742
21,864
20,095
Net Property, Plant & Equipment
1,620
2,383
5,490
9,633
11,825
13,681
Total Investments and Advances
26
142
63
78
21
58
Long-Term Note Receivable
1,166
48
3
3
3
118
Intangible Assets
-
-
-
322
727
655
Other Assets
31,692
2,882
2,245
2,343
3,997
3,884
Total Assets
61,713
34,777
30,549
30,038
39,475
39,354
ST Debt & Current Portion LT Debt
5
5
8
6
4
Accounts Payable
2,856
3,080
3,277
2,789
5,059
Income Tax Payable
3
2,678
31
21
1,541
Other Current Liabilities
6,024
7,822
2,476
4,386
9,395
Total Current Liabilities
8,889
13,585
5,792
7,202
15,999
Long-Term Debt
36
26
16
10
6
Provision for Risks & Charges
32,793
2,722
2,852
2,723
2,875
Deferred Taxes
923
831
1,011
916
1,037
Other Liabilities
50
53
57
35
23
Total Liabilities
41,816
16,487
8,716
9,970
18,902
Common Equity (Total)
19,896
18,288
21,831
20,069
20,573
Total Shareholders' Equity
19,896
18,288
21,831
20,069
20,573
Total Equity
19,896
18,288
21,831
20,069
20,573
Liabilities & Shareholders' Equity
61,713
34,777
30,549
30,038
39,475
Non-Equity Reserves
2
2
2
-
-
About GlaxoSmithKline Pharmaceuticals
View Profile
